Spotlight on Dinutuximab in the Treatment of High-Risk Neuroblastoma: Development and Place in Therapy

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s114530
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Dinutuximab Combination Therapy Becomes First Approval for High-Risk Neuroblastoma

Journal of Community and Supportive Oncology
OncologyHematology
2015English

Spotlight on Perampanel in the Management of Seizures: Design, Development and an Update on Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Benralizumab in the Treatment of Severe Asthma: Design, Development and Potential Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Abatacept in the Treatment of Polyarticular JIA: Development, Clinical Utility, and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2011English

Spotlight on Ixekizumab for the Treatment of Moderate-To-Severe Plaque Psoriasis: Design, Development, and Use in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Osimertinib in the Treatment of Non-Small-Cell Lung Cancer: Design, Development and Place in Therapy

Lung Cancer: Targets and Therapy
Oncology
2017English

Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: Design, Development, and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Tildrakizumab in the Treatment of Psoriasis: Latest Evidence and Place in Therapy

Therapeutic Advances in Chronic Disease
Medicine
2019English

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy